申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP1837329A1
公开(公告)日:2007-09-26
A compound of the following formula (1), or its prodrug or pharmaceutically acceptable salt thereof, being useful as a diabetic medicine or preventive, or blood sugar regulator, or therapeutic agent for hyperlipemia, etc.
wherein the ring Z is an optionally substituted heteroaryl, W4 is a single bond, lower alkylene, etc., Ar2 is an optionally substituted aryl, etc., W3 is a single bond, lower alkylene, etc., Ar1 is an optionally substituted arylene, etc., each of W1 and W2 is an optionally substituted lower alkylene, etc., and R1 is carboxyl, an alkoxycarbonyl.
下式(1)化合物或其原药或药学上可接受的盐,可用作糖尿病药物或预防药物,或血糖调节剂,或高脂血症治疗剂等。
其中,环 Z 是任选取代的杂芳基,W4 是单键、低级亚烷基等,Ar2 是任选取代的芳基等,W3 是单键、低级亚烷基等,Ar1 是任选取代的芳基等,W1 和 W2 各自是任选取代的低级亚烷基等,R1 是羧基、烷氧羰基。